Home' Australian Pharmacist : Australian Pharmacist January 2016 Contents Australian Pharmacist January 2016 I © Pharmaceutical Society of Australia Ltd.
Queensland: the odd state out
BY DENISE L HOPE, STEVEN T DICKFOS & MICHELLE A KING
Did you know that not all Australian states and territories have legislated Continued Dispensing?
The PBS initiative to supply statins or
oral contraceptives to a consumer with
immediate need but no prescription
was launched in 2012.
1,2 Queensland is
currently the only state yet to legislate
continued dispensing,3 making it
illegal to provide medicines under the
Queensland is also the only state that
prohibits pharmacists from supplying
S2 or S3 medicines to persons under
16 years of age without prescription,
(s286(1)) or under 14 years in the
case of salbutamol or terbutaline
asthma inhalers.3 (s286(5)) As many
emergency medicines are classified S3,
including adrenaline and emergency
a pharmacist practising
in Queensland could not legally supply
these medicines to a minor.
The Queensland Government is
currently drafting new medicines and
poisons legislation but whether these
discrepancies will be addressed is
1. Australian Government Department of Human Services.
Education guide - Continued Dispensing Initiative - PBS
requirements. 2015; http://www.humanservices.gov.
Accessed 4 Nov 2015.
2. Pharmaceutical Society of Australia. Guidelines for the
Continued Dispensing of eligible prescribed medicines
by pharmacists. 2012; https://www.psa.org.au/download/
dispensing-practice-guide.pdf. Accessed 4 November
3. Queensland Parliamentary Council. Health (Drugs
and Poisons) Regulation 1996 2015, at: https://
HealDrAPoR96.pdf. Accessed 12 Oct 2015.
4. Therapeutic Goods Administration. Poisons Standard
(Standard for Uniform Scheduling of Medicines and
Poisons) No. 8 . 2015; https://www.comlaw.gov.au/Details/
F2015L00844/Download. Accessed 12 Oct 2015.
Denise L Hope, BPharm, MMedRes,
GradCertHigherEd; Lecturer, School of Pharmacy,
Griffith University, Queensland, Australia.
Steven T Dickfos, BSc (Oceanography),
BPharmaceutSci, MPharm; Flight Lieutenant,
Royal Australian Air Force (RAAF), Canberra,
Michelle A King, BPharm, PhD (Med); Senior
Lecturer, Menzies Health Institute Queensland
and School of Pharmacy, Griffith University,
» LEGAL GEMS
PPIs Appendix H listed from
The Appendix H listing of Proton Pump inhibitors (PPIs) from 1 February
will provide community pharmacists with a great opportunity to talk to
consumers and counsel on correct use of PPIs
The Appendix H list means that
pharmaceutical companies will be
allowed to advertise PPIs directly
to consumers. This in turn will, over
time, lead to more consumer inquiries
about Schedule 3 PPIs, which means
the consumer must speak to their
pharmacist about them.
PSA’s Lead Coach for PSA’s Health
Destination Pharmacy Program, Rachel
Dienaar, told Australian Pharmacist
that when the Appendix H listing
takes effects and direct-to-consumer
advertising begins, more people will be
aware of the Schedule 3 PPIs and drive
more people into pharmacies asking
‘ This will provide a great opportunity for
pharmacists focused on patient centred
care to initiate a health conversation
with their customer, providing them
with the opportunity to increase the
consumer’s knowledge in this area
and contribute to improved health
outcomes,’ Ms Dienaar said.
‘And, importantly, it provides an
opportunity to identify and advise on
whether a PPI is actually appropriate
based on the customer’s self-diagnosis,
and whether that self-diagnosis is, in
‘From there the pharmacist can either
refer them on to a GP if necessary,
provide self-care advice – including
lifestyle modification information –
or recommend an appropriate product.
‘Alternatively the customer could
benefit from a professional service
delivered by the pharmacy, for example
a MedsCheck, if they are eligible, or a
smoking cessation program.
‘Of course, by increasing pharmacist
consumer engagement, a more holistic
solution is provided. In some cases this
may lead to other health issues being
identified, or more products and services
being required – for example, adding on
an antacid to provide immediate relief for
someone with frequent heartburn while
the PPI takes effect.
‘By giving the customer a positive
experience and offering a solution to
their problem, in this case heartburn,
customer-focused pharmacists can build
loyalty in customers by taking the time
to listen, advise and provide a solution
to the customer’s problem.
‘ This translates into better profit from
Pharmacist Only products and from
providing a complete solution for the
customer and reducing channel leakage
‘Repositioning pharmacists to
allow them to utilise their skills
and knowledge is the concept
underpinning the Health Destination
Links Archive Australian Pharmacist December 2015 Australian Pharmacist February 2016 Navigation Previous Page Next Page